Cura Seating Clinical Case Study

Clinical Case Study Poster Improving Comfort for Patients with Advanced Huntington’s Disease Using the Cura Legacy Chair

Introduction to Sue Ryder Care

Sue Ryder Care is a prominent healthcare charity known for its specialist palliative, neurological, and community-based services. Their mission is to provide expert and compassionate care to individuals living with serious illnesses and conditions, as well as their families, aiming to help restore quality of life. The organization operates across England and Scotland, supporting patients with complex needs, including conditions such as Huntington’s Disease, stroke, and motor neurone disease.

Purpose of the Study

This case study explores the impact of introducing the Cura Legacy Chair from Cura Seating at Sue Ryder Care’s Stagenhoe facility, specifically for patients in the advanced stages of Huntington’s Disease (HD). The trial period spanned from December 1st, 2008, to December 27th, 2009. The goal was to assess the suitability of the Cura Legacy Chair for these patients, enhancing their comfort and well-being.

Background: The Need for a New Seating Solution

Prior to this trial, patients with advanced Huntington’s Disease at Stagenhoe were using the Omega Chair by Kirton Healthcare. While no direct comparison was made between the Omega Chair and the Cura Legacy Chair, staff felt that a fresh seating solution might offer improved comfort and postural support.

Understanding Huntington’s Disease

Huntington’s Disease (HD) is a progressive neurodegenerative disorder that affects movement, cognition, and behaviour. The disease is typically divided into five stages of progression, ranging from early symptoms to advanced stages where mobility, communication, and daily activities become severely limited. In advanced stages, patients require significant physical support to maintain comfort and safety, making seating solutions critical.

The Cura Legacy Chair Trial

On December 1st, 2008, Sue Ryder Care introduced the Cura Legacy Chair into the care routine of patients with advanced Huntington’s Disease. Designed to provide superior pressure relief and postural support, the Cura Legacy Chair offers features that are particularly beneficial for patients with reduced mobility. The chair’s adjustable settings, cushioning, and air-cell technology work to alleviate pressure points and maintain proper alignment, reducing the risk of pressure sores and improving overall comfort.

Outcome and Observations

Throughout the trial, Sue Ryder Care staff observed noticeable improvements in patient comfort and posture. The adjustable nature of the Cura Legacy Chair allowed for tailored support, which was particularly beneficial for individuals in the advanced stages of Huntington’s Disease who were no longer able to reposition themselves. The chair’s design helped reduce physical strain on the caregivers, as its functionality made it easier to adjust patients’ seating positions with minimal effort.

Overall, the introduction of the Cura Legacy Chair at Sue Ryder Care’s Stagenhoe facility demonstrated that it provided a significant enhancement to the care and comfort of patients with advanced Huntington’s Disease.

Conclusion

This case study highlights the importance of selecting appropriate seating solutions for patients with complex neurological conditions. The Cura Legacy Chair proved to be a valuable addition to the care provided at Sue Ryder Care, enhancing patient comfort, supporting postural needs, and easing the workload of caregivers. The findings reinforce the need for ongoing innovation in care equipment to improve the quality of life for individuals living with advanced neurological conditions.